Found 22 matching trials
A Trial of Camrelizumab Combined With Famitinib Malate in Treatment NaĆÆve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer PHASE3 The study is being conducted to evaluate the efficacy, and safety of camrel...
Show More Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer PHASE3 This study is a randomized, open-label, controlled, multi-center Phase III ...
Show More Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer PHASE2 This study is a randomized, open-label, double-cohort, national multi-cente...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Famitinib Malate in HER2-negative Metastatic Breast Cancer PHASE2 The hypothesis of this clinical research study is to discover if the study ...
Show More Location
Fudan University Cancer Hospital
Learn More & Join Trial
Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer PHASE2 This study is an open-label, multi-center Phase II clinical study, aimed to...
Show More Location
Multiple Locations
Learn More & Join Trial
Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects PHASE1 This is a single-center, randomized, open-label study to compare the pharma...
Show More Location
Xiangya Hospital Central South University
Learn More & Join Trial
Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy PHASE2 This study employs a randomized, controlled, exploratory clinical trial des...
Show More Location
Shandong First Medical University Affiliated Cancer Hospital
Learn More & Join Trial
A Phase I Study of Famitinib Malate in Patients With Solid Tumor PHASE1 Famitinib is a novel oral multitargeted tyrosine kinase inhibitor with anti...
Show More Location
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
A Drug-drug Interaction Study of Famitinib Malate With a Proton Pump Inhibitor in Healthy Adult Subjects PHASE1 The primary objective is to evaluate the effect of omeprazole on the pharma...
Show More Location
Zhongda Hospital, Affiliated to Southest University
Learn More & Join Trial
Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting Condition PHASE1 The study is a single-centre, randomized, open, 2-period, 2-sequence crosso...
Show More Location
The First Affiliated Hospital of USTC
Learn More & Join Trial